Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

Blood (2021) 138 (Supplement 1): 2607.

https://doi.org/10.1182/blood-2021-149147

Published: 2021

Journal Articles

Laboratory Prognostic Index (LaPI) : Three Laboratory Variables Are Able to Stratify Diffuse Large B-Cell Lymphoma NOS Patients in Prognostic Clusters at Diagnosis

Fernando Martin Moro, Juan Marquet Palomanes, Jesus Villarrubia, Ana Lario Arribas, Alberto Gonzalez Rodriguez, Beatriz Astibia Mahillo, Maria Isabel Delgado Trillo, Claudia Lopez Prieto, Federico Santiago Herrera, Gemma Moreno Jiménez, Valentín Garcia Gutierrez, Jose Antonio Garcia Vela, Javier Lopez Jimenez

Blood (2021) 138 (Supplement 1): 2505.

https://doi.org/10.1182/blood-2021-151025

Published: 2021

Journal Articles

Prognostic Impact of the Latency Time from the Administration of Cytotoxic Therapy to the Development of Therapy-Related Myeloid Neoplasms

Claudia Nunez-Torron, MD, Adolfo Saez, Berta Mercedes Michael Fernández, Irene Garcia-Garcia, Juan Marquet Palomanes, Miguel Piris-Villaespesa, MD, Jesus Villarrubia, PhD, Valentín Garcia-Gutiérrez, MD PhD, Gemma Moreno Jiménez, MD, Javier Lopez Jimenez, MD PhD, Pilar Herrera Puente

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-141907

Published: 2020

Journal Articles

Prognosis of Acute Myeloid Leukemia with Myelodysplasia-Related Changes According to the Different Subgroups of the WHO 2016 Classification in Patients Candidates to Intensive Chemotherapy

Claudia Nunez-Torron, MD, Juan Marquet Palomanes, Valentín Garcia-Gutiérrez, MD PhD, Adolfo Saez, Alejandro Luna, MD, Jesus Villarrubia, PhD, Gemma Moreno Jiménez, MD, Javier Lopez Jimenez, MD PhD, Pilar Herrera Puente

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-141683

Published: 2020

Journal Articles

Survival Analysis According to Minimal Residual Disease By Flow Cytometry in Acute Myeloid Leukemia after First Induction

Claudia Nunez-Torron, MD, Juan Marquet Palomanes, MD, Fernando Martín Moro, Adolfo Saez-Martin, MD, Alejandro Luna, MD, Irene Garcia-Garcia, Berta Mercedes Michael Fernández, Jesus Villarrubia, PhD, Miguel Piris-Villaespesa, MD, Ernesto Roldan Santiago, Eulalia Rodríguez Martín, Gemma Moreno, MD, Valentín García Gutiérrez, PhD, Javier Lopez Jimenez, MD PhD, Pilar Herrera Puente

Blood (2019) 134 (Supplement_1): 1433.

https://doi.org/10.1182/blood-2019-130190

Published: 2019

Journal Articles

Proposal of a "2-Step-Algorithm" for the Screening of Myeloproliferative Neoplasms in Individuals with Erythrocytosis

Miguel Piris-Villaespesa, MD, Gloria Muñoz-Martin, PhD, Claudia Stock, PhD, Adolfo Saez-Martin, MD, Ricardo Sanchez, PhD MD, Javier Zamora, Francisco Javier del Castillo, Jesus Villarrubia, PhD, Javier Lopez Jimenez, MD PhD, Joaquin Martinez-Lopez, MD PhD, Valentin Garcia Gutierrez, MD PhD

Blood (2019) 134 (Supplement_1): 4187.

https://doi.org/10.1182/blood-2019-127389

Published: 2019

Journal Articles

Twenty-Five Years Diagnosing Gaucher’s Disease in Spain, What We Have Learned?

Marcio M Andrade-Campos, PhD, Jose L Capablo, PhD, Jesus J Fraile, PhD, Mercedes Roca-Espiau, PhD, Pilar Irun, PhD, Jorge J Cebolla, MSc, Laura Lopez de Frutos, PhD, Izaskun Arenaz, MSci, Jesus Villarrubia, PhD, Abelardo Barez, PhD, Horacio Cano, MD, Teresa Molero, PhD, Lucia Villalon, PhD, Pilar Giraldo, PhD

Blood (2018) 132 (Supplement 1): 1110.

https://doi.org/10.1182/blood-2018-99-115474

Published: 2018

Journal Articles

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Marcio M Andrade-Campos, PhD, Jorge J Cebolla, MSc, Laura Lopez de Frutos, PhD, Pilar Irun, PhD, Soledad Noya, MD, Santiago Nieto, MD, Lucia Villalon, PhD, Ana I Arribas, MD, Abelardo Barez, PhD, Javier Garcia-Frade, PD, Maria Lourdes Hermosin, MD, Jesús-María Hernández-Rivas, MD PhD, Daiana Ibarretxe, MD, Maria L Lozano, MD PhD, Teresa Molero, PhD, Maria Angeles Perez-Saenz, MDPhD, Jesus Villarrubia, PhD, Pilar Giraldo, PhD

Blood (2018) 132 (Supplement 1): 4942.

https://doi.org/10.1182/blood-2018-99-115534

Published: 2018

Journal Articles

Prevalence of JAK2 V617F in Individuals That Meet World Health Organization Erythrocytosis Criteria for Polycythemia Vera

Miguel Piris-Villaespesa, Gloria Muñoz-Martin, PhD, Ricardo Sanchez, Claudia Nuñez-Torron, MD, Adolfo Saez-Martin, MD, Borja Fernandez-Felix, Javier Zamora, Francisco Javier del Castillo, Jose Manuel del Rey, Javier Lopez Jimenez, MD PhD, Jesus Villarrubia, PhD, Joaquin Martinez Lopez, MD PhD, Valentín García Gutiérrez, PhD

Blood (2018) 132 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2018-99-110619

Published: 2018

Journal Articles

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: Discordance between Histology and Flow Cytometry in Bone Marrow Examination at Diagnosis

Fernando Martín Moro, Miguel Piris-Villaespesa, Monica Garcia Cosio, MD, Jesus Villarrubia, PhD, Juan Marquet Palomanes, MD, Ana Lario Arribas, MD, Eulalia Rodríguez Martín, María Calbacho, MD, Irene Garcia-Garcia, Berta Mercedes Michael Fernández, Carla Martínez-Geijo Román, Kyra Velázquez-Kennedy, Alejandro Sanz, Pilar Herrera Puente, Gemma Moreno Jiménez, Jose Valentín García Gutiérrez, MD PhD, Javier Lopez Jimenez, MD PhD

Blood (2018) 132 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2018-99-117041

Published: 2018

Journal Articles

Inter-Observer Discordance With The Diagnosis Of Myelodysplastic Syndromes With Less Than 5% Bone Marrow Blasts: Unilineage Vs Multilineage Dysplasia and Reproducibility Of The Threshold Of 2% Blasts

Patricia Font, Javier Loscertales, Carlos Soto, Pilar Ricard, Carolina Muñoz Novas, Estela Martin-Clavero, Montserrat Lopez-Rubio, Luis Garcia-Alonso, Marta Callejas, Alfredo Bermejo, Celina Benavente, Monica Ballesteros, Teresa Cedena, María Calbacho, Raquel Urbina, Jesus Villarrubia, Ana Villegas

Blood (2013) 122 (21): 2768.

https://doi.org/10.1182/blood.V122.21.2768.2768

Published: 2013

NARROW

Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

Laboratory Prognostic Index (LaPI) : Three Laboratory Variables Are Able to Stratify Diffuse Large B-Cell Lymphoma NOS Patients in Prognostic Clusters at Diagnosis

Prognostic Impact of the Latency Time from the Administration of Cytotoxic Therapy to the Development of Therapy-Related Myeloid Neoplasms

Prognosis of Acute Myeloid Leukemia with Myelodysplasia-Related Changes According to the Different Subgroups of the WHO 2016 Classification in Patients Candidates to Intensive Chemotherapy

Survival Analysis According to Minimal Residual Disease By Flow Cytometry in Acute Myeloid Leukemia after First Induction

Proposal of a "2-Step-Algorithm" for the Screening of Myeloproliferative Neoplasms in Individuals with Erythrocytosis

Twenty-Five Years Diagnosing Gaucher’s Disease in Spain, What We Have Learned?

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Prevalence of JAK2 V617F in Individuals That Meet World Health Organization Erythrocytosis Criteria for Polycythemia Vera

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: Discordance between Histology and Flow Cytometry in Bone Marrow Examination at Diagnosis

Inter-Observer Discordance With The Diagnosis Of Myelodysplastic Syndromes With Less Than 5% Bone Marrow Blasts: Unilineage Vs Multilineage Dysplasia and Reproducibility Of The Threshold Of 2% Blasts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only